What is Dogwood Therapeutics's depreciation?

Dogwood Therapeutics (DWTX) reported depreciation of $17.26K in Q2 2025.

How has Dogwood Therapeutics's depreciation changed year-over-year?

Dogwood Therapeutics's depreciation increased by 466.8% year-over-year, from $3.04K to $17.26K.

Dogwood Therapeutics DWTX Depreciation

Depreciation at other companies

Collegium Pharmaceutical, Inc.COLL

——

Avanos MedicalAVNS

——

LON

LeonaBio, Inc. Common StockLONA

——

Amylyx Pharmaceuticals, Inc.AMLX

——

PTH

Pelthos Therapeutics Inc.PTHS

——

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Dogwood Therapeutics’s 10-Q, filed August 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's depreciation?: Dogwood Therapeutics (DWTX) reported depreciation of $17.26K in Q2 2025.
How has Dogwood Therapeutics's depreciation changed year-over-year?: Dogwood Therapeutics's depreciation increased by 466.8% year-over-year, from $3.04K to $17.26K.